Hinge Health, INC Form 4 insider transactions

NYSE
Hinge Health's Chief Financial Officer, James Budge, has filed a Form 4 detailing planned sales of Class A Common Stock in February 2026 under a pre-arranged 10b5-1 trading plan.
NYSE
Funds affiliated with Hinge Health director Elliott Robinson sold over 183,000 shares of Class A Common Stock in two separate transactions.
NYSE
Hinge Health CEO Daniel Antonio Perez converted Class B shares to Class A and subsequently gifted Class A shares, impacting indirect beneficial ownership.
NYSE
Hinge Health CEO Daniel Antonio Perez sold 166,665 shares of Class A Common Stock for approximately $40.26 per share under a pre-arranged trading plan.
NYSE
Hinge Health President James Pursley disposed of 1,429 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health's Chief Financial Officer, James Budge, disposed of 3,036 shares of Class A Common Stock to cover tax liabilities related to vested restricted stock units.
NYSE
Hinge Health CEO Daniel Antonio Perez reported the sale of 166,665 Class A Common Stock shares on January 5, 2026, executed under a pre-arranged 10b5-1 trading plan.
NYSE
Hinge Health President James Pursley disposed of 1,118 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health's Chief Financial Officer, James Budge, reported the disposition of 3,243 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health, Inc. President James Pursley reported the sale of 15,000 Class A Common Stock shares at a weighted average price of $48.3967, executed under a Rule 10b5-1 trading plan.
NYSE
Hinge Health's Chief Financial Officer, James Budge, sold 10,491 shares of Class A Common Stock for approximately $48.41 per share under a pre-arranged trading plan.
NYSE
Hinge Health CEO Daniel Perez executed pre-planned sales of Class A common stock totaling approximately $8.09 million, following a conversion from Class B shares.
NYSE
Hinge Health's Chief Financial Officer, James Budge, reported a pre-planned gift of 20,000 Class A Common Stock shares.
NYSE
Hinge Health CEO Daniel Antonio Perez reported the conversion of Class B shares to Class A, followed by a gift of Class A common stock.
NYSE
A director and 10% owner of Hinge Health, Elliott Robinson, reported an indirect sale of Class A Common Stock by Bessemer Venture Partners funds.
NYSE
Insight Holdings Group and related entities reported the conversion and sale of over 1.6 million Hinge Health Class A Common Stock shares for $47.76 each.
NYSE
Hinge Health's President, James Pursley, disposed of 5,126 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Bessemer Venture Partners, linked to Hinge Health Director Elliott Robinson, sold over 244,000 shares of Class A Common Stock in late November 2025.
NYSE
Hinge Health's Chief Financial Officer, James Budge, disposed of 8,213 Class A Common Stock shares at $48.91 each to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health's CFO, James Budge, sold 44,589 shares of Class A Common Stock on November 25, 2025, under a pre-arranged 10b5-1 trading plan.
NYSE
Hinge Health President James Pursley sold a total of 15,900 shares of Class A Common Stock on November 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Hinge Health Director Kristina M. Leslie reported a pre-planned sale of 1,250 shares of Class A Common Stock scheduled for November 21, 2025.
NYSE
Hinge Health's Chief Financial Officer, James Budge, sold 781 shares of Class A Common Stock for $44.78 per share under a pre-arranged trading plan.
NYSE
Bessemer Venture Partners, a 10% owner and director, converted Class B shares to Class A and subsequently sold 725,000 shares of Hinge Health, Inc. common stock for $40.05 per share.
NYSE
Bessemer Venture Partners, affiliated with Hinge Health Director Elliott Robinson, converted Class B to Class A shares and subsequently sold a portion of Class A common stock.
NYSE
Hinge Health Director Kristina M. Leslie reported sales of Class A Common Stock totaling 6,000 shares over two days.
NYSE
Hinge Health President James Pursley disposed of 15,977 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.
NYSE
Hinge Health CFO James Budge disposed of 34,903 Class A Common Stock shares to cover tax liabilities from vested restricted stock units.
NYSE
Gabriel M.I. Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, exercised stock options to acquire 326,807 shares of Class B Common Stock.
NYSE
Daniel Perez's spouse exercised stock options to acquire 35,470 shares of Hinge Health Class A Common Stock, with no shares sold.